Results 181 to 190 of about 78,794 (295)
NAT‐GS was significantly more effective only in patients with one tumor marker above the reference range, comparing those who achieved 12‐month MRFS with those who did not. ABSTRACT Aim Pancreatic cancer (PC) remains one of the most lethal malignancies, with early recurrence severely affecting prognosis even after curative resection.
Hiromichi Kawaida +9 more
wiley +1 more source
In advanced colorectal cancer, tumors with mature tertiary lymphoid structures (TLS) exhibited abundant infiltration of CD3‐ and CD8‐positive lymphocytes in both primary and metastatic sites, indicating an activated immune response. The presence of mature TLS was also associated with favorable chemotherapy sensitivity and improved prognosis.
Nobuhiro Hosoi +9 more
wiley +1 more source
Heterogeneity of SOX9 and HNF1β in Pancreatic Ducts Is Dynamic. [PDF]
Rezanejad H +10 more
europepmc +1 more source
Intercalated duct cell is starting point in development of pancreatic ductal carcinoma? [PDF]
Ryo Wada +4 more
openalex +1 more source
Biomarkers for the Early Detection of Pancreatic Ductal Adenocarcinoma
Carl Borrebaeck +2 more
openalex +2 more sources
ABSTRACT Background Self‐expandable metal stents (SEMS) are often used for preoperative biliary drainage in pancreatoduodenectomy (PD); however, their impact on postoperative intra‐abdominal infection (POAI) remains unclear. This study aimed to evaluate the clinical significance of SEMS in relation to POAI.
Kosuke Mori +9 more
wiley +1 more source
Digital subtraction imaging with carbon dioxide and liquid contrast in the biliary and pancreatic ducts. [PDF]
Maruyama A +6 more
europepmc +1 more source
Killer on the road?-cells from pancreatic preneoplastic lesions disseminate through pancreatic ducts on their way to cancer. [PDF]
Schäfer H, Traulsen A, Sebens S.
europepmc +1 more source
Incorporating a new criteria of resectability for pancreatic ductal adenocarcinoma [PDF]
Marcos Belotto +4 more
openalex +1 more source

